Human rhinovirus 14 (ATCC® VR-284AS/RB)

Classification: Picornaviridae, Rhinovirus, Human rhinovirus B  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Picornaviridae, Rhinovirus, Human rhinovirus B
Agent Human rhinovirus 14
Strain Rhinovirus 14 antiserum
Applications
Cross reactions: tested against VR-1300 (Rhinovirus type 100 virus antigen) and found not to neutralize the viral effect
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
Source of antibody: rabbit (NZW) by intradermal injection
Product Format frozen
Comments
Immunogen: Picornavirus, Rhinovirus, human, type 14, strain 1059, (ATCC VR-284)
Source of antibody: rabbit (NZW) by intradermal injection
Propagated in: H1-HeLa (ATCC CRL-1958)
Treatment: whole virus after fluorocarbon extraction
Adjuvant: Freund's complete and incomplete
Cross reactions: tested against VR-1300 (Rhinovirus type 100 virus antigen) and found not to neutralize the viral effect
Preparation: pooled rabbit sera
Effect on Host
Cross reactions: tested against VR-1300 (Rhinovirus type 100 virus antigen) and found not to neutralize the viral effect
Effect on Host
Cross reactions: tested against VR-1300 (Rhinovirus type 100 virus antigen) and found not to neutralize the viral effect
Name of Depositor ATCC
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation